4 studies found for:    11119474 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)
Conditions: Coronary Disease;   Angina, Unstable
Interventions: Drug: Abciximab;   Drug: Placebo
2 Completed Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)
Condition: Myocardial Infarction
Interventions: Drug: Abciximab;   Other: Placebo Heparin Sodium
3 Completed Gastrointestinal Ulceration in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Condition: Acute Coronary Syndrome
Intervention: Procedure: Video Capsule Endoscopy
4 Completed 75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
Condition: Coronary Disease
Intervention: Drug: Clopidogrel

Indicates status has not been verified in more than two years